News

Filter

Current filters:

ViramuneAnti-virals

News briefs: Genmab/GSK, Gilead and Mylan

24-05-2012

Denmark's Genmab (OMX: GEN) yesterday received a milestone payment of 20 million Danish kroner ($3.4…

Anti-viralsBiotechnologycobicistatFinancialGenericsGenmabGilead SciencesGlaxoSmithKlineMylan LaboratoriesOncologyRegulationViramune

Breckenridge in generic Viramune deal with Zhejiang Huahai Pharma

07-05-2012

Privately-held US generic drugmaker Breckenridge Pharmaceutical that it has finalized its agreement with…

Anti-viralsAsia-PacificBoehringer IngelheimBreckenridge PharmaceuticalsGenericsMarkets & MarketingNevirapineNorth AmericaPatentsViramuneZhejiang Huahai Pharma

Boehringer once-daily AIDS drug Viramune cleared in EU

21-09-2011

Independent German drug major Boehringer Ingelheim says that once-daily Viramune (nevirapine) prolonged-release…

Anti-viralsBoehringer IngelheimEuropePharmaceuticalRegulationViramune

European Commission approves label change for Boehringer Ingelheim’s Viramune; US FDA updates on Pradaxa

17-09-2010

The European Commission has approved an update to the Summary of Product Characteristics (SmPC) for independent…

Anti-viralsBoehringer IngelheimCardio-vascularEuropeNorth AmericaPharmaceuticalPradaxaRegulationViramune

South Africa’s PMTCT program showing dramatic results in HIV-positive women

14-12-2009

The percentage of HIV-positive mothers who pass the virus to their newborn babies in South Africa's KwaZulu-Natal…

Anti-viralsGeneralHealthcareNevirapinePharmaceuticalRest of the WorldRetrovirViramuneZidovudine

COMPANY SPOTLIGHT

Menarini

Back to top